Dynamic changes of microglia/macrophage M1 and M2 polarization in Theiler’s
2
murine encephalomyelitis1
3
Vanessa Herder1,2*, Cut Dahlia Iskandar1,2*, Kristel Kegler1,2, Florian Hansmann1,2,
4
Suliman Ahmed Elmarabet1, Muhammad Akram Khan1,2, Arno Kalkuhl3, Ulrich
5
Deschl3, Wolfgang Baumgärtner1,2, Reiner Ulrich1,2,, Andreas Beineke1,2,4,
Accepted Article
1
6 7
1
8
Germany
9
2
10
3
11
KG, Biberach (Riss), Germany
12
*authors have contributed equally; authors have contributed equally
Department of Pathology, University of Veterinary Medicine Hannover, Hannover,
Center for Systems Neuroscience, Hannover, Germany Department of Non-Clinical Drug Safety, Boehringer Ingelheim Pharma GmbH & Co.
13 14
4
15
Prof. Dr. Andreas Beineke, Dipl. ECVP
16
Department of Pathology
17
University of Veterinary Medicine Hannover
18
Bünteweg 17
19
D-30559 Hannover, Germany
20
Mail:
[email protected] 21
Phone: 0049-511-953-8640
22
Fax: 0049-511-953-8675
corresponding author
23
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between thiversion and the Version of Record. Please cite this article as doi: 10.1111/bpa.12238
1 This article is protected by copyright. All rights reserved.
Accepted Article
24 25
Abstract
26
Microglia and macrophages play a central role for demyelination in Theiler’s murine
27
encephalomyelitis (TME) virus-infection, a commonly used infectious model for
28
chronic-progressive multiple sclerosis. In order to determine dynamic changes of
29
microglia/macrophage polarization in TME, the spinal cord of SJL mice was
30
investigated by gene expression profiling and immunofluorescence. Virus persistence
31
and demyelinating leukomyelitis was confirmed by immunohistochemistry and
32
histology. Electron microscopy revealed continuous myelin loss together with abortive
33
myelin repair during the late chronic infection phase, indicative of incomplete
34
remyelination. A total of 59 genes out of 151 M1- and M2-related genes were
35
differentially expressed in TMEV-infected mice over the study period. The onset of
36
virus-induced demyelination was associated with a dominating M1-polarization, while
37
mounting M2-polarization of macrophages/microglia together with sustained
38
prominent M1-related gene expression were present during the chronic progressive
39
phase. Molecular results were confirmed by immunofluorescence, showing an
40
increased spinal cord accumulation of CD16/32+ M1-, arginase-1+ M2- and Ym1+ M2-
41
type cells associated with progressive demyelination. The present study provides a
42
comprehensive database of M1/M2-related gene expression involved in the initiation
43
and progression of demyelination supporting the hypothesis that perpetuating
44
interaction between virus and macrophages/microglia induces a vicious circle with
45
persistent inflammation and impaired myelin repair in TME.
46
2 This article is protected by copyright. All rights reserved.
Accepted Article
47 48
Introduction
49
Multiple sclerosis (MS), one of the most frequent central nervous system (CNS)
50
diseases in young adults, is a chronic demyelinating disease of unknown etiology
51
and possibly multifactorial causes (13). Based on the generation of myelin-specific
52
immune responses, MS is regarded as an autoimmune disease (4, 68), presumably
53
triggered by virus infections (33, 63). Due to clinical and pathological similarities,
54
Theiler’s murine encephalomyelitis (TME) represents a commonly used infectious
55
animal model for the chronic-progressive form of human MS (14, 59, 62, 74).
56
Following intracerebral infection with a low virulent BeAn-strain of Theiler’s murine
57
encephalomyelitis virus (TMEV) susceptible mouse strains develop persistent CNS
58
infection with immune mediated spinal cord demyelination and remyelination failure
59
(26, 29, 41, 46, 55, 60, 86, 87, 90).
60
Microglia and CNS-infiltrating macrophages play a central role in the pathogenesis of
61
TMEV-induced demyelination. They represent target cells for viral persistence during
62
the chronic disease phase (40, 76) and contribute to myelin damage by the release
63
of myelinotoxic factors (bystander demyelination), delayed-type hypersensitivity
64
reaction and induction of myelin-specific autoimmunity (48, 56). Similarly, microglia
65
induce myelin damage also in autoimmune and toxic rodent models for MS, such as
66
experimental
67
demyelination,
68
microglia/macrophages plasticity describes different cell populations with distinct and
69
even opposing functions. For instance, M1-type microglia/macrophages promote
70
inflammation, which leads to protective immunity against pathogens but if
autoimmune respectively
encephalomyelitis (47,
80,
93).
(EAE) The
and
cuprizone-induced
current
concept
of
3 This article is protected by copyright. All rights reserved.
uncontrolled also to immune mediated tissue damage by the release of pro-
72
inflammatory cytokines, reactive oxygen species and nitric oxide (69, 71). In contrast,
73
M2-type cells exhibit neuroprotective properties usually during advanced disease
74
stages due to phagocytosis of debris, promoting tissue repair and termination of
75
neuroinflammation by down-regulating M1- and Th1-immune responses (43).
76
So far, only few reports mention the polarizing effects of TMEV upon microglia in vitro
77
(24). Moreover, M1- and M2-type cells represent merely two extremes of the
78
polarization continuum and macrophages/microglia with an intermediate activation
79
status can be observed inter alia in demyelinating MS lesions (92), demonstrating the
80
need for quantitative analyses of M1/M2-related factors in myelin disorders. Thus, the
81
aims of the present study were to (i) select candidate genes involved in
82
macrophage/microglia polarization by DNA microarray analyses and (ii) to compare
83
their transcription levels to get insights in M1/M2 balances during the initiation and
84
progression of virus-induced demyelination. In addition, (iii) dynamic changes of M1-
85
and M2-type cells in TME were determined with the aid of immunofluorescence.
Accepted Article
71
86 87
4 This article is protected by copyright. All rights reserved.
Materials and Methods
Accepted Article
88 89 90
Experimental design
91
Five-week-old female SJL/J mice (Harlan, Borchen, Germany) were inoculated into
92
the right cerebral hemisphere with 1.63x106 plaque-forming units/mouse of the
93
BeAn-strain of TMEV in 20µl Dulbecco’s Modified Eagle Medium (PAA
94
Laboratories, Cölbe, Germany) with 2% fetal calf serum and 50µg/kg gentamicin.
95
Mock-infected animals received 20µl of the vehicle only. Inoculation was carried
96
under general anesthesia with medetomidine (0.5 mg/kg, Domitor, Pfizer, Karlsruhe,
97
Germany) and ketamine (100 mg/kg, Ketamine 10%, WDT eG, Garbsen, Germany).
98
All experiments were performed in groups of six TMEV- and 3-6 mock-infected
99
mice, euthanized 14, 42, 98 and 196 days post infection (dpi). For histology,
100
immunohistochemistry and special stains, thoracic spinal cord segments were
101
removed immediately after death and fixed in 10% formalin for 24 hours, decalcified
102
in disodium-ethylenediaminetetraacetate for 48 h and subsequently embedded in
103
paraffin wax. For microarray analysis and immunofluorescence, spinal cords were
104
immediately removed, snap-frozen in liquid nitrogen and stored at -80°C (28, 65,
105
90).
106
The animal experiments were approved and authorized by the local authorities
107
(Niedersächsisches Landesamt für Verbraucherschutz- und Lebensmittelsicherheit
108
[LAVES], Oldenburg, Germany, permission number: 33.9.42502-04/07/1331, 509c-
109
42502-02/589 and 33-42502-05/963).
110
5 This article is protected by copyright. All rights reserved.
Histology
112
Leukomyelitis was evaluated on hematoxylin and eosin (HE)-stained transversal
113
sections using a semiquantitative scoring system based upon the degree of
114
perivascular infiltrates: 0 = no changes, 1 = scattered perivascular infiltrates, 2 = 2
115
to 3 layers of perivascular inflammatory cells, 3 = more than 3 layers of perivascular
116
inflammatory cells, as described previously (23). For the evaluation of myelin loss,
117
serial sections of spinal cord were stained with Luxol fast blue-cresyl violet
118
(LFB-CV) and the degree of demyelination was semi-quantitatively evaluated as
119
follows: 0 = no change, 1 = 25%, 2 = 25-50% and 3 = 50-100% of the white matter
120
affected (23). The scoring was performed separately on all 4 quarters of spinal cord
121
transversal sections. For each animal the arithmetic average of leukomyelitis and
122
myelin loss was calculated. Histological data used for the present study were
123
generated in our previous studies (89, 90).
Accepted Article
111
124 125
Immunohistochemistry
126
Immunohistochemistry was performed using a polyclonal rabbit anti-TMEV capsid
127
protein VP1-specific antibody, as described before (39). Briefly, for blocking of the
128
endogenous peroxidase, formalin-fixed, paraffin-embedded tissue sections were
129
treated with 0.5% H2O2 diluted in methanol for 30 minutes at room temperature.
130
Subsequently, slides were incubated with the primary antibody at a dilution of 1:2000
131
for 16 hours at 4°C. Goat-anti-rabbit IgG diluted 1:200 (BA9200, H+L, Vector
132
Laboratories, Burlingame, CA, USA) was used as a secondary antibody for one hour
133
at room temperature. Sections used as negative controls were incubated with rabbit
134
normal serum at a dilution of 1:2000 (Sigma-Aldrich Chemie GmbH, Taufkirchen, 6 This article is protected by copyright. All rights reserved.
Germany). Slides were subsequently incubated with the peroxidase-conjugated
136
avidin-biotin complex (ABC method, PK-6000, Vector laboratories, Burlingame, CA,
137
USA) for 30 minutes at room temperature. After the positive antigen-antibody reaction
138
visualization by incubation with 3.3-diaminobenzidine-tetrachloride in 0.1M imidazole,
139
sections were counterstained with Mayer’s hematoxylin.
Accepted Article
135
140 141
Immunofluorescence
142
Methanol-fixed frozen sections of the thoracic spinal cord were rinsed in 0.1% Triton
143
X-100 (Sigma-Aldrich, Taufkirchen, Germany) in phosphate buffered saline (PBS) for
144
30 minutes. Non-specific binding was blocked with 20% goat or horse serum,
145
respectively, diluted in PBS/0.1% Triton X-100/1% bovine serum albumin for 30
146
minutes After washing with 0.1 % Triton X-100 in PBS, slides were incubated with
147
primary CD68- (monoclonal rat anti-mouse antibody, Ab53444, clone FA-11, Abcam
148
Ltd.; dilution 1:200) and CD107b- (monoclonal rat anti-mouse antibody MCA2293,
149
clone
150
macrophages/microglia. For visualization of M1-type macrophages/microglia a
151
CD16/32-specific antibody (monoclonal rat anti-mouse, 553141, clone 2.4G2, BD
152
Pharmingen; dilution 1:25) and for M2-type cells an arginase-1-specific antibody
153
(polyclonal goat anti-human, SC-18351, Santa Cruz Biotechnology; dilution 1:50) and
154
a Ym1-specific antibody (polyclonal rabbit anti-mouse antibody, ab93034, Abcam
155
Ltd.; dilution 1:100) were used. Slides were incubated for one hour, followed by
156
washing in PBS/0.1% Triton X-100. As negative control, slides were incubated with
157
goat, rat or rabbit serum in the same concentration as the primary antibodies.
158
Subsequently slides were incubated with secondary DyLight 488-conjugated donkey
M3/84,
AbD
Serotec;
dilution
1:200)
for
the
detection
of
7 This article is protected by copyright. All rights reserved.
anti-goat (Jackson ImmunoResearch Laboratories, Dianova; dilution 1:200), Cy2-
160
conjugated goat anti-rabbit IgG antibodies (Jackson ImmunoResearch Laboratories,
161
Dianova; 1:200) and Cy3-conjugated goat anti-rat (Jackson ImmunoResearch
162
Laboratories, Dianova; dilution 1:200), respectively, for one hour at room temperature
163
and afterwards washed in PBS.
164
For double staining, slides were simultaneously incubated for 90 minutes with the
165
CD107b-specific monoclonal antibody (see above) and primary antibodies directed
166
against CCL5 (polyclonal rabbit anti-human antibody; ABIN674949, antibodies-online
167
GmbH dilution 1:10), CXCL10 (polyclonal rabbit anti-mouse antibody; ABIN687442,
168
antibodies-online GmbH dilution 1:10), interferon-γ (polyclonal rabbit anti-human
169
antibody, ABIN669141, antibodies-online GmbH; dilution 1:20), and TMEV
170
(polyclonal rabbit anti-TMEV BeAn VP1 antibody; dilution 1:2000 (39)), respectively.
171
Cy2-conjugated goat anti-rat (Jackson ImmunoResearch Laboratories, Dianova;
172
dilution 1:200) and Cy3-conjugated goat anti-rabbit (Jackson ImmunoResearch
173
Laboratories, Dianova; dilution 1:200) secondary antibodies were simultaneously
174
used to visualize the respective antigens (see above). Nuclear counterstaining was
175
performed with 0.01% bisbenzimide (H33258, Sigma Aldrich) for 10 minutes and
176
sections were mounted with Dako Fluorescent Mounting medium (Dako Diagnostika).
Accepted Article
159
177 178
Statistical analyses
179
For
180
immunofluorescence, a Mann-Whitney-U-test was performed. A p-value of less than
181
0.05 was considered as statistically significant.
non-category
data
obtained
by
histology,
immunohistochemistry
and
8 This article is protected by copyright. All rights reserved.
Accepted Article
182 183
Electron microscopy
184
Electron microscopy was performed as described previously (38, 91). Spinal cord
185
samples were fixated with 2.5% glutaraldehyde and incubated overnight at 4°C. Post-
186
fixation was performed in 1% aqueous osmium tetroxide and after five washes in
187
cacodylate buffer (five minutes each) samples were dehydrated through series of
188
graded alcohols and embedded in Epon 812 medium. Semi-thin sections were cut on
189
a microtome (Ultracut Reichert-Jung, Leica Microsystems, Germany) and stained
190
with uranyl citrate for 15 minutes. After eight washing steps samples were incubated
191
with lead citrate for seven minutes. Ultra-thin sections were cut with a diamond knife
192
(Diatome, USA) and transferred to copper grids. For descriptive ultrastructural
193
analyses of white matter changes one hundred axons and their myelin sheaths per
194
animal were examined for the presence of degenerative changes (myelin sheath
195
vacuolization, myelin loss) and regeneration (oligodendrocyte-type remyelination,
196
Schwann cell-type remyelination) by a transmission electron microscope (EM 10C,
197
Zeiss, Germany). For quantification of phagocytic activity (gitter cell morphology,
198
presence of myelin fragments and/or apoptotic bodies within the cytoplasm) a total of
199
one hundred macrophages/microglia were investigated.
200 201 202
Microarray analyses
203
RNA was isolated from frozen spinal cord samples using the RNeasy Mini Kit
204
(Qiagen, Hilden, Germany), amplified and labeled using the Message Amp II-Biotin 9 This article is protected by copyright. All rights reserved.
Enhanced Kit (Ambion, Austin, USA) and hybridized to GeneChip mouse genome
206
430 2.0 arrays (Affymetrix, Santa Clara, USA) as described (90). Six biological
207
replicates were used per group and time point, except for five TMEV-infected mice at
208
98 dpi. Background adjustment and quantile normalization was performed using
209
RMAExpress (6). MIAME compliant data set are deposited in the ArrayExpress
210
database (E-MEXP-1717; http://www.ebi.ac.uk/arrayexpress).
Accepted Article
205
211 212
Selection of M1- and M2-associated genes
213
For molecular characterization of macrophage/microglia polarization a data set of
214
genes differentially expressed in the spinal cord of TMEV-infected SJL mice obtained
215
in our previous global gene expression analysis was used (90). The present analyses
216
focused
217
microglia/macrophages (Supplemental Table S1) according to peer-reviewed
218
publications (15, 17, 35, 54). The fold change was calculated as the ratio of the
219
inverse-transformed arithmetic means of the log2-transformed expression values of
220
TMEV-infected versus mock-infected mice. Down-regulations are shown as negative
221
reciprocal values.
222
Statistics, version 20, IBM Corporation, Armonk, USA) comparing TMEV- and mock-
223
infected mice were calculated followed by adaption of the p-values according to the
224
method described by Storey and Tibshirani using QVALUE 1.0 (84). Significantly
225
differentially expressed genes between TMEV- and mock-infected mice were
226
selected employing a q-value 0.05 cutoff combined with a 2.0 or -2.0 fold-change
227
filter. The relative percentage of differentially expressed M1- versus M2-marker
on a
list
of
genes
Independent
associated
pair-wise
with
M1- or
M2-polarization of
Mann-Whitney-U-tests (IBM SPSS
10 This article is protected by copyright. All rights reserved.
genes was compared for each time point employing Fisher’s exact tests (p-value
229
0.05).
Accepted Article
228
230 231
Results
232
Histological scoring of spinal cord inflammation and demyelination
233
Histological data used for the present study were generated in our previous studies
234
(89, 90). Examination of the HE-stained spinal cord sections revealed a
235
mononuclear inflammation (leukomyelitis) within the white matter of TMEV-infected
236
mice beginning at 14 dpi. The inflammatory changes increased towards 98 dpi and
237
were significantly increased compared to mock-infected control animals at all
238
investigated time points: 14 dpi (p=0.011), 42 dpi (p=0.002), 98 dpi (p=0.013) and
239
196 dpi (p=0.002; Figure 1 and 2). The amount of demyelination increased until 196
240
dpi (Figure 1 and 2). At 3 investigated time points (42, 98 and 196 dpi),
241
demyelination in the spinal cord of TMEV-infected SJL-mice was significantly
242
increased compared to mock-infected control mice (p=0.002, p=0.007, p=0.002) as
243
determined by the myelin stain LFB-CV (Figure 1 and 2).
244 245
Quantification of virus load in the spinal cord and virus detection in CD107b+
246
microglia/macrophages
247
Immunohistochemistry for the detection of virus protein in the spinal cord of TMEV-
248
infected mice revealed infection at all investigated time points (14, 42, 98, and 196
249
dpi). While at 14 dpi infected cells were found scattered in the grey and white matter,
250
with the onset of demyelination at 42 dpi positive cells were located predominantly in 11
This article is protected by copyright. All rights reserved.
lesions of the ventral spinal cord white matter (Supplemental figure S1). No positive
252
signals were observed in mock-infected control mice.
253
Immunofluorescence
254
macrophage/microglia infection. Results showed that at 14 dpi 25-50%, at 42 dpi 40-
255
57%, at 98 dpi 38-67%, and at 196 dpi 33-58% of TMEV-infected cells represent
256
CD107b+ macrophages/microglia (Supplemental figure S2).
Accepted Article
251
double
staining
was
performed
to
demonstrate
257 258
Characterization of myelin alterations and regeneration by electron microscopy
259
Descriptive ultrastructural analyses revealed subtle myelin changes before the onset
260
of overt demyelination at 14 dpi in an average of 0.3% of investigated axons,
261
characterized by vacuolization of myelin sheaths. At 42 dpi 2.2% of axons showed
262
myelin sheath vacuolization and 5.8% of axons showed a complete loss of myelin
263
(Figure 3). At 98 dpi an average of 2.8% of vacuolated myelin sheaths were observed
264
and 8.4% of axons were totally denuded in demyelinated foci. At 196 dpi 5.0% of
265
axons within white matter lesions showed a complete loss of myelin sheath, while
266
2.5% of axons showed oligodendrocyte-type remyelination and 0.7% Schwann cell-
267
type remyelination (Figure 3; Supplemental table S2), indicative of beginning but
268
abortive myelin repair (91). Remyelination by Schwann cells was characterized by
269
the presence of oval to signet ring-shaped cells in close proximity to axons,
270
ensheathing axons with myelin on a one-to-one basis (Figure 3; 20, 96).
271
Phagocytosis of myelin fragments associated with denuded axons, representing a
272
hallmark of active demyelination, was observed starting 42 dpi. At this time point an
273
average of 40.2% of microglia/macrophages displayed gitter cell morphology with 12
This article is protected by copyright. All rights reserved.
phagocytized myelin in the cytoplasm (myelinophages; Figure 3). At 98 and 196 dpi,
275
50.1% and 51.5% of investigated macrophages/microglia represent myelinophages.
276
In addition, phagocytized apoptotic bodies were present in an average of 9.3% of
277
macrophages/microglia at 42 dpi, followed by a decline at 98 (0.7%) and 196 dpi
278
(0.5%; Supplemental table S2).
Accepted Article
274
279 280
Quantification of M1- and M2-related gene expression by DNA microarray
281
analyses
282
In order to get insights into polarization related to microglia/macrophages, DNA
283
microarray analyses of spinal cord tissue have been performed. A total of 151 genes
284
related to macrophages/microglia-polarization were extracted from peer-reviewed
285
publications, of which 72 and 66 were unequivocally assigned as M1- and M2-marker
286
genes, respectively. Thirteen genes were assigned to both polarization types
287
(Supplemental table S1).
288
A total of 59 genes (39.1%) were differentially expressed in TMEV-infected mice over
289
the study period (Figure 4, supplemental table S3). Most strikingly, although the
290
number of differentially expressed genes increased over the study period for both
291
phenotypes, comparison of the relative proportion of differentially expressed M1-
292
versus M2-marker genes revealed a significantly higher percentage of differentially
293
expressed M1-marker genes at 14 (p=0.035) and 42 dpi (p = 0.016). In addition, a
294
statistical tendency (p = 0.078) of increased M1-associated genes was observed at
295
98 dpi, whereas a comparable proportion of M1- and M2-marker genes was detected
296
at later time points (Figure 4). 13
This article is protected by copyright. All rights reserved.
According to the function, differentially expressed genes were assigned to seven
298
pathways, including chemotaxis (group I; 15 genes), phagocytosis, antigen
299
processing and presentation (group II; 16 genes), cytokine and growth factor
300
signaling (group III; 12 genes), Toll-like receptor signaling (group IV; 2 genes),
301
apoptosis (Group V; 4 genes), extracellular matrix interaction and cell adhesion
302
(group VI; 5 genes), and miscellaneous genes not related to a specific pathway
303
(group VII; 5 genes; supplemental table S3). In group I, 53.3% of genes (8/15 genes)
304
were up-regulated on 14 dpi, while at subsequent time points nearly all genes were
305
significantly up-regulated. In group II and III 62.5% of genes (10/16 genes) and
306
50.0% of genes (6/12), respectively were up-regulated at 14 dpi, followed by an up-
307
regulation of nearly all genes at 42, 98, and 196 dpi in both groups. Tlr1 (group IV)
308
was significantly transcribed at 42, 98, and 196, while expression of Tlr2 was
309
observed during the entire observation period. 75% of apoptosis-related genes (3/4
310
genes; group V) were significantly up-regulated in infected mice at 14 dpi and 100%
311
at subsequent time points. While at 14 dpi 40.0% of genes (2/5 genes), all genes
312
(100%) were up-regulated at 42, 98, and 196 dpi. Miscellaneous genes not assigned
313
to a specific pathway (group VII) included Atf3, Arg1, Cepba, Chi3l3 and Hexb. No
314
genes were differentially expressed at 14 dpi. Atf3, Arg1, and Cebpa were
315
significantly increased at 42, 98 and 196 dpi, while the M2-marker Chi3l3 (aka Ym1)
316
was only transcribed during the late chronic phase at 196 dpi (Supplemental table
317
S3).
Accepted Article
297
318 319
Temporal changes of macrophages/microglia subsets and verification of DNA
320
microarray results by immunofluorescence 14
This article is protected by copyright. All rights reserved.
Immunofluorescence was used to confirm the results obtained by gene expression
322
profiling. The number of microglia/macrophages increased over time in the spinal
323
cord
324
microglia/macrophages in the late stages of the disease. CD16/32 + M1- and also
325
arginase-1+ M2-type cells were significantly increased compared to non-infected
326
animals at 42, 98 and 196 dpi (Figure 5 and 6). Interestingly, a significant increase of
327
Ym1+ M2-type cells was found only at 98 and 196 dpi (Figure 5 and 6), suggestive of
328
late M2-polarization during the chronic demyelinating phase. To further substantiate
329
this, statistical analyses between the early (42 dpi) and late demyelinating phase
330
(196 dpi) have been performed. Results revealed a significant time-dependent
331
increase of CD107+ macrophages/microglia (p = 0.006), arginase-1+ M2-type cells (p
332
= 0.042), and Ym1+ M2-type cells (p = 0.009), while no significant temporal
333
differences were observed for CD68+ macrophages/microglia and CD16/32+ M1-type
334
cells (data not shown). Accordingly, the ratio of arginase-1+ M2-type cells to
335
CD16/32+ M1-type cells (p = 0.044) and the ratio of Ym1+ M2-type cells to CD16/32+
336
M1-type cells (p = 0.008) significantly increased over time (Figure 5), characteristic of
337
mounting M2-responses during disease progression.
338
Employing the Spearman’s rank correlation coefficient, the amounts of all
339
investigated macrophage/microglia proteins (CD68, CD107b, CD16/32, arginase-1,
340
Ym1) were significantly, positively correlated with the expression level of the
341
respective genes (Table 1).
342
In order to demonstrate expression of M1-related chemokines (CCL5 and CXCL10)
343
and interferon (IFN)-γ in macrophages/microglia during the early (42 dpi) and late
344
demyelinating phase (196 dpi) immunofluorescence double staining has been
Accepted Article
321
of
infected
mice
with
highest
numbers
of
CD107b+
and
CD68+
15 This article is protected by copyright. All rights reserved.
performed. Results revealed that both chemokines are preferentially expressed by
346
macrophages/microglia in spinal cord white matter lesions, since at 42 dpi 91-100%
347
and at 196 dpi 80-92% of CCL5-positive cells represent CD107+ cells (Supplemental
348
figure S3 and S4). Similarly, co-localization with CD107b was observed in 70-100%
349
at 42 dpi and in 80-94% of cells expressing CXCL10 at 196 dpi (Supplemental figure
350
S3 and S4). At 42 dpi 52-80% and at 196 dpi 72-93% of IFN-γ-positive cells are co-
351
labeled with CD107b (Supplemental figure S3 and S4), showing that in addition to
352
CNS-infiltrating lymphocytes (64) also macrophages/microglia contribute to IFN-γ
353
production in demyelinating lesions of TMEV-infected mice.
Accepted Article
345
354
355
16 This article is protected by copyright. All rights reserved.
Discussion
357
The present study provides a comprehensive database of M1/M2-related genes
358
expressed during the initiation and progression of TME. Although most molecules are
359
produced also by other resident CNS cells and recruited lymphocytes (11, 27), all
360
selected genes can be transcribed by macrophages/microglia and are involved in
361
their polarization, respectively (15, 17, 35, 54). Results revealed an imbalance of
362
M1/M2-responses during the onset of virus-induced demyelination, characterized by
363
the dominance of CD16/32+ M1-type cells and disproportionally elevated M1-related
364
gene expression in the spinal cord of infected mice. With disease progression an
365
accumulation of arginase-1+ and Ym1+, potentially neuroprotective M2-type cells (12,
366
61, 79) together with mounting transcription of M2-related genes was found.
367
However, sustained prominent M1-responses emphasize the importance of innate
368
immunity for immunopathology and progressive myelin loss in demyelinating
369
disorders, as discussed for MS (52, 92).
370
Differentially expressed M1-related genes at 14 dpi in the spinal cord of TMEV-
371
infected mice predominately consist of factors, such as chemokines, involved in the
372
CNS recruitment of macrophages, T cells and B cells (Table S3, group I).
373
Simultaneously, migration of CD68+ antigen presenting cells and activation of genes
374
related to innate and adaptive immunity within the CNS-draining cervical lymph node
375
has been observed in TMEV-infected mice during the acute phase of the disease in
376
our previous study (66). Under neuroinflammatory conditions, chemokines and their
377
receptors are produced by different cell types, such as microglia, astrocytes, neurons
378
and infiltrating leukocytes (85). In the present study, double labeling revealed that
379
macrophages/microglia are a major source of CCL5 (aka RANTES) and CXCL10
Accepted Article
356
17 This article is protected by copyright. All rights reserved.
(aka IP-10) within demyelinating lesions, which are preferentially expressed by M1-
381
type cells (51). In TME, both chemokines have been shown to critically control
382
leukocyte CNS influx and antiviral immune responses, respectively (57, 75, 77). In
383
addition, CCL5 and CXCL10 are up-regulated in the EAE model and the
384
cerebrospinal fluid of MS patients during demyelinating events, demonstrating their
385
functional role in immune mediated damage (18, 50, 81). Interestingly Ym1, detected
386
by microarray analysis and immunofluorescence, also displays chemotactic activity
387
and has been demonstrated to promote Th2 cytokine expression (9, 94), which might
388
reduce Th1-mediated immunopathology but probably also protective antiviral
389
immunity in TMEV-infected susceptible mice strains.
390
M1-responses are a hallmark of early innate immunity following viral infection
391
mediated by the interaction between microglial toll-like receptors (Table S3, group IV)
392
and cellular compounds (damage associated molecular pattern) and pathogen
393
associated molecular pattern, respectively (35, 36). However, besides their pivotal
394
role for antiviral immunity, microglia have been demonstrated to induce also myelin-
395
specific adaptive Th1-responses in TMEV-infected mice (67). Similarly, M1-polarized
396
cells foster immunopathology in primary autoimmune CNS disorders (58) and the
397
drug
398
macrophages/microglia from a M1- to a protective M2-phenotype (47). In addition,
399
selective inhibition of M1-type microglia by minocycline treatment reduces
400
neurodegeneration as demonstrated in mouse models for amyotrophic lateral
401
sclerosis (37). Similar to TME, experimental spinal cord injury in mice leads to
402
microglial polarization into a pro-inflammatory and neurotoxic M1-phenotype, which
403
might function as an early trigger of degeneration and immunological events at later
404
disease stages (35). Excessive microglial responses can be observed also in human
Accepted Article
380
Fasudil
ameliorates
the
clinical
severity
of
EAE
by
shifting
18 This article is protected by copyright. All rights reserved.
and canine spinal cord trauma, which leads to potentially destructive effects by the
406
release of pro-inflammatory cytokines, proteolytic molecules and reactive oxygen
407
species (2, 3, 19, 53, 72, 82, 83). Taken together, an imbalance towards M1-
408
dominance represents a potential prerequisite for lesion initiation in TME as currently
409
discussed for MS (22). Similar to findings in the present study, early innate immune
410
responses with activated pro-inflammatory microglia can be detected in pre-
411
demyelinating and early demyelinating MS lesions, which are supposed to induce
412
myelin damage and immunopathology (21, 52).
413
In the present study, the onset of demyelination and phagocytosis of myelin and
414
apoptotic cells is accompanied by an up-regulation of genes involved in antigen
415
processing, presentation and T cell stimulation (Table S3, group II). The functional
416
relevance of phagocytic macrophages/microglia for the pathogenesis of CNS
417
damage is discussed controversially. On the one hand, phagocytosis of myelin debris
418
enhances CNS regeneration following traumatic injury (95). Moreover, ingestion of
419
myelin induces a foamy appearance and anti-inflammatory function of cultured
420
human macrophages and myelinophages within MS lesions acquire a M2-phenotype,
421
which are supposed to contribute to resolution of inflammation and tissue repair (8).
422
In addition, phagocytosis of apoptotic cells by cultured rodent microglia leads to
423
diminished pro-inflammatory cytokine production with a reduced ability to activate T
424
cells (49). On the other hand, incorporation of myelin and cellular debris by microglia
425
is able to enhance their antigen presenting and myelin-specific T cell stimulatory
426
capacity in vitro (5, 10). Furthermore, isolated rat microglia exposed to myelin have
427
been described to develop a neurotoxic phenotype with an increased inducible nitric
428
oxide synthase, tumor necrosis factor-α and glutamate expression (69) .
Accepted Article
405
19 This article is protected by copyright. All rights reserved.
Microarray analysis revealed the transcription of several genes participating in the
430
interferon pathway predominately during the demyelinating phase (Table S3, group
431
III). In TME, microglia/macrophages activated by virus or IFN-γ enhance immune
432
mediated tissue damage by presenting viral antigens and endogenous myelin
433
epitopes to CD4+ T cells, which induces delayed type hypersensitivity and
434
autoimmunity, respectively (7, 16, 34, 70). Moreover, beside its protective antiviral
435
function, IFN-γ increases the migration of macrophages and microglial activation,
436
which induces myelinotoxic substances and free radicals causing progressive myelin
437
loss (bystander demyelination) in TME (46, 59, 88, 89). IFN-γ is the main cytokine
438
associated with M1-activation of microglia and macrophages (35, 71) and has been
439
shown in TMEV-infected mice to be produce by CD4+ and CD8+ T cells (64).
440
Noteworthy, demonstration of the cytokine in CD107b+ cells in the present study is
441
indicative also of an autocrine regulation of M1-polarization, as demonstrated in
442
endotoxin-stimulated macrophages (78).
443
Despite mounting M2-polarization and the expression of regeneration promoting
444
factors, such as insulin like growth factor-1 (igf1) and transforming growth factor-β
445
(Tgfb1) (25, 42, 93), CNS recovery remains abortive and only insufficient
446
remyelination attempts by oligodendrocytes and Schwann cells were found in the
447
spinal cord during the late chronic TME phase. Similar to the present observation,
448
macrophages/microglia with both M1- and M2-properities can be found in active
449
demyelinating MS brain lesions (92). Recent studies have demonstrated that the
450
switch of M1- into M2-type cells is required for efficient oligodendrocyte differentiation
451
and myelin repair following toxin-induced demyelination in rodents and that M2-
452
conditoned media drive oligodendrocyte maturation in vitro (61). In addition, M2-type
453
macrophages/microglia protect from EAE through deactivation of encephalitogenic
Accepted Article
429
20 This article is protected by copyright. All rights reserved.
Th1 and Th17 cells (73). Consequently, continuous M1-polarization observed till the
455
late chronic phase (196 dpi) in TMEV-infected mice has the potential to antagonize
456
neuroprotective effects of M2-microglia/macrophages. In agreement with previous
457
reports (40, 97), CD107+ microglia/macrophages represent a target for virus infection
458
in the present study. Since TMEV has been demonstrated to preferentially infect
459
activated myeloid cells with M1-charateristics, such as CD16/32 and IFN-γ
460
expression, in vitro (30, 31), it is also tempting to speculate that prolonged M1-
461
polarization contributes to viral persistence in susceptible mouse strains by providing
462
permissive target cells for TMEV. In addition, genes have been identified by the
463
present microarray analysis that might be involved in disturbed viral elimination by
464
influencing the interferon pathway (Table S3, group III). For instance, OASL1, a
465
recently defined type I interferon negative regulator and translation inhibitor of IRF7 is
466
differentially up-regulated in TMEV-infected mice. OASL1 causes T cell suppression
467
in persistent lymphocytic choriomeningitis virus infection of mice, and is regarded as
468
a new target for preventing chronic infectious diseases (44, 45). In agreement with
469
this idea, subpopulations of CNS-infiltrating macrophages have been demonstrated
470
to reduce protective antiviral immunity by inducing T cell exhaustion which leads to
471
virus persistence in TMEV-infected mice (32). Besides this, M2-polarized cells have
472
the ability to reduce antiviral immunity, as described for human cytomegalovirus
473
infection (1).
474
In conclusion, the perpetuating interaction between virus and macrophages/microglia
475
induces a vicious circle with continuous inflammation and impaired myelin repair in
476
the spinal cord of TMEV-infected mice. The present findings support the hypothesis
477
of a dual function of either polarized cells with promoting effects upon antiviral
478
immunity and immunopathology, respectively, in TME. Hence, in contrast to the
Accepted Article
454
21 This article is protected by copyright. All rights reserved.
therapeutic effect of M2-dominence in primary autoimmune diseases, such as EAE,
480
only a well-orchestrated and timely balanced polarization of macrophages/microglia
481
might have the ability to prevent virus persistence and reduce myelin loss in this
482
infectious MS model.
Accepted Article
479
483
484
485
Acknowledgements
486
The authors would like to thank Caroline Schütz, Kerstin Schöne, Danuta Waschke,
487
Bettina Buck and Petra Grünig for their excellent technical support during the
488
laboratory work and Dr. Karl Rohn for statistical analyses. This study was supported
489
by the German Research Foundation (FOR 1103, BA 815/10-2, BE 4200/1-2 and UL
490
421/1-2).
491
492
493
494
495
496
22 This article is protected by copyright. All rights reserved.
Figure legends
498
Figure 1
499
Histological lesions in the spinal cord of Theiler´s murine encephalomyelitis virus-
500
infected mice. A) Lymphocytic meningitis (arrows) and B) mild vacuolization of the
501
spinal cord white matter in an infected animal at 42 days post infection. C) Prominent
502
infiltration of macrophages/microglia in the spinal cord and lymphocytic meningitis
503
(arrow) at 196 days post infection. D) Demyelination of the spinal cord white matter
504
(asterisks) at 196 days post infection. E) Higher magnification of C) showing
505
activated macrophages/microglia with a foamy cytoplasm (gitter cells). F) Note
506
accumulation of myelin debris within the cytoplasm of macrophages/microglia,
507
indicative of myelinophagia. GM = gray matter; bars = 300µm (A-D) and 30µm (E-F);
508
hematoxylin-eosin stain (A,C,E), luxol fast blue stain (B,D,F).
Accepted Article
497
509 510
Figure 2
511
Scoring of demyelinating leukomyelitis in Theiler´s murine encephalomyelitis virus-
512
infected mice. A) Histology reveals inflammatory responses in the spinal cord
513
(leukomyelitis) at all investigated time points. B) Detection of demyelination in the
514
spinal cord white matter at 42, 98 and 196 days post infection. dpi = days post
515
infection; mock = mock-infected control mice; TMEV = Theiler´s murine
516
encephalomyelitis virus-infected mice; = significant difference (p≤0.05, Mann-
517
Whitney-U-test). Box and whisker plots display median and quartiles with maximum
518
and minimum values.
519
23 This article is protected by copyright. All rights reserved.
Figure 3
521
Ultrastructural analyses of the spinal cord white matter of Theiler`s murine
522
encephalomyelitis virus-infected mice by transmission electron microscopy. A)
523
Macrophages/microglia containing phagocytized myelin fragments (white asterisks)
524
at 42 days post infection, characteristic of myelinophagia (M = nucleus of a
525
macrophage/microglial cell; magnification 13300x). B) Demyelinated axons (black
526
asterisks) lacking myelin sheaths and focal myelin vacuolization (arrow) in an
527
infected mouse at 96 days post infection. For comparison, myelinated axons with
528
intact myelin sheaths are labelled with triangles (magnification 6600x). C)
529
Oligodendrocyte in proximity to multiple remyelinated axons with thin myelin sheaths
530
(black asterisks) during late chronic infection phase (196 days post infection),
531
indicative of oligodendrocyte-mediated remyelination. Normally myelinated axons are
532
labelled with triangles (O = nucleus of an oligodendrocyte; magnification 5300x). D)
533
Schwann cell remyelination in a demyelinated area at 196 days post infection,
534
characterized by comparatively thick newly formed myelin sheaths (arrows) and a
535
one Schwann cell per axon relationship (S = nucleus of a Schwann cell;
536
magnification 6650x).
Accepted Article
520
537
538
Figure 4
539
Expression profile of M1- and M2-related genes in the spinal cord during the course
540
of Theiler´s murine encephalomyelitis. A) Heat map displays fold changes, indicated
541
by a color scale ranging from –4 (relative low expression) in green to 4 (relative high
542
expression) in red. 59 out of 151 selected genes are differentially expressed in
543
infected mice. B) Comparison of the relative proportion (percentage) of differentially 24
This article is protected by copyright. All rights reserved.
expressed M1- versus M2 marker genes employing the fisher´s exact test revealed a
545
significant dominance ( = p0.05) of M1-related genes at 14 and 42 days post
546
infection (dpi). A statistical tendency (p = 0.078) of an increased M1-associated gene
547
expression is observed at 98 dpi, whereas comparable proportions of M1- and M2-
548
marker genes are detected at 196 dpi.
Accepted Article
544
549 550
Figure 5
551
Quantification of different macrophage/microglia subsets in the spinal cord of
552
Theiler´s murine encephalomyelitis virus-infected mice by immunofluorescence.
553
Significant increase of A) CD68+ cells, B) CD107b+ cells, C) CD16/CD32+ cells, and
554
D) arginase-1+ cells at 42, 98 and 196 days post infection (dpi) and of E) Ym1+ cells
555
at 98 and 196 dpi in infected mice compared to mock-infected control mice. TMEV =
556
Theiler´s murine encephalomyelitis virus-infected mice; mock = mock-infected control
557
mice; = significant difference (p≤0.05, Mann-Whitney-U-test). Box and whisker plots
558
display median and quartiles with maximum and minimum values. F) Significantly
559
elevated ratios of arginase-1+ M2-type cells to CD16/32+ M1-type cells (arginase-
560
1:CD16/32) and Ym1+ M2-type cells to CD16/32+ M1-type cells (Ym1:CD16/32) at
561
196 dpi compared to 42 dpi. Columns display median with maximum and minimum
562
values. = significant difference (p≤0.05, Mann-Whitney-U-test).
563
564
Figure 6
565
Detection of different macrophage/microglia subsets in the spinal cord of Theiler`s
566
murine encephalomyelitis virus-infected mice by immunofluorescence. Accumulation
567
of A) CD107b+ cells, B) CD68+ cells, C) arginase-1 (Arg-1)+ cells, D) CD16/32+ cells, 25
This article is protected by copyright. All rights reserved.
and E) Ym1+ cells in the spinal cord white matter at 196 days post infection. Inserts
569
show higher magnifications of labelled cells. BIS = bisbenzimide (blue nuclear
570
counterstain).
Accepted Article
568
571
572
26 This article is protected by copyright. All rights reserved.
Supporting material:
Accepted Article
573
574 575
Figure S1
576
Detection of Theiler´s murine encephalomyelitis virus in the murine spinal cord by
577
immunohistochemistry. A) Quantification of infected cells at different time points.
578
TMEV = Theiler´s murine encephalomyelitis virus-infected mice; mock = mock-
579
infected control mice; dpi = days post infection; = significant difference (p≤0.05,
580
Mann-Whitney-U-test). Box and whisker plots display median and quartiles with
581
maximum and minimum values. B) Note virus-specific labeling (brownish signal) in
582
the spinal cord white matter of an infected mouse at 98 dpi. Scale bar = 200 µm;
583
insert; scale bar = 50 µm.
584 585
Figure S2
586
Phenotyping of Theiler´s murine encephalomyelitis virus-infected cells (TMEV) by
587
immunofluorescence double staining. A) Percentage of infected cells representing
588
CD107b+ macrophages/microglia at different days post infection (dpi). Columns
589
display median with maximum and minimum values. B) Co-localization of TMEV
590
(green) and CD107b (red) in an inflammatory spinal cord lesion at 98 dpi. Double-
591
stained cells exhibit a yellow color. Nuclei are stained with bisbenzimide (blue).
592
Scale bars = 50 µm.
593 594
Figure S3
595
Detection of chemokines and interferon-γ (IFN-γ) in CD107b+ macrophages/microglia
596
by immunofluorescence double staining. Percentage of A) CCL5-, B) CXCL10- and 27
This article is protected by copyright. All rights reserved.
C) IFN-γ-positive cells co-expressing CD107b at 42 and 196 days post infection (dpi).
598
Columns display median with maximum and minimum values.
Accepted Article
597
599 600
Figure S4
601
Detection of chemokines and interferon-γ (IFN-γ) in CD107b+ macrophages/microglia
602
in the spinal cord by immunofluorescence double staining. Top row: co-localization of
603
CCL5 (green) and CD107b (red) in an infected mouse at 196 days post infection
604
(dpi). Middle row: co-localization of CXCL10 (green) and CD107b (red) in an infected
605
mouse at 196 dpi. Bottom row: co-localization of IFN-γ (green) and CD107b (red) in
606
an infected mouse at 42 dpi. Double-stained cells exhibit a yellow color (right
607
column). Nuclei are stained with bisbenzimide (blue). Scale bars = 50 µm.
608 609 610
28 This article is protected by copyright. All rights reserved.
References
612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656
1. Avdic S, Cao JZ, McSharry BP, Clancy LE, Brown R, Steain M, Gottlieb DJ, Abendroth A, Slobedman B (2013) Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. Journal of virology 87:10273-10282. 2. Banati RB, Kreutzberg GW (1993) Flow cytometry: measurement of proteolytic and cytotoxic activity of microglia. Clinical neuropathology 12:285-288. 3. Beineke A, Markus S, Borlak J, Thum T, Baumgärtner W (2008) Increase of pro-inflammatory cytokine expression in non-demyelinating early cerebral lesions in nervous canine distemper. Viral immunology 21:401-410. 4. Bernard CC, de Rosbo NK (1991) Immunopathological recognition of autoantigens in multiple sclerosis. Acta neurologica 13:171-178. 5. Beyer M, Gimsa U, Eyupoglu IY, Hailer NP, Nitsch R (2000) Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitro. Glia 31:262-266. 6. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. 7. Borrow P, Tonks P, Welsh CJ, Nash AA (1992) The role of CD8+T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. The Journal of general virology 73 ( Pt 7):1861-1865. 8. Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ, Boot RG, Aerts JM, Amor S, Nieuwenhuis EE, Laman JD (2006) Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain : a journal of neurology 129:517-526. 9. Cai Y, Kumar RK, Zhou J, Foster PS, Webb DC (2009) Ym1/2 promotes Th2 cytokine expression by inhibiting 12/15(S)-lipoxygenase: identification of a novel pathway for regulating allergic inflammation. J Immunol 182:5393-5399. 10. Cash E, Zhang Y, Rott O (1993) Microglia present myelin antigens to T cells after phagocytosis of oligodendrocytes. Cellular immunology 147:129-138. 11. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS, Mackay CR (2004) T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 173:68-78. 12. Colombo L, Parravicini C, Lecca D, Dossi E, Heine C, Cimino M, Wanke E, Illes P, Franke H, Abbracchio MP (2014) Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion: effect of neuroprotective agents. Neurochem Int 66:43-54. 13. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502-1517. 14. Dal Canto MC, Melvold RW, Kim BS, Miller SD (1995) Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microscopy research and technique 32:215-229. 15. David S, Kroner A (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nature reviews Neuroscience 12:388-399.
Accepted Article
611
29 This article is protected by copyright. All rights reserved.
16. Drescher KM, Pease LR, Rodriguez M (1997) Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunological reviews 159:177-193. 17. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, BarOr A, Antel JP (2012) Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60:717-727. 18. Elhofy A, Kennedy KJ, Fife BT, Karpus WJ (2002) Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors. Immunol Res 25:167-175. 19. Ensinger E-M, Boekhoff TMA, Carlson R, Beineke A, Rohn K, Tipold A, Stein VM (2010) Regional topographical differences of canine microglial immunophenotype and function in the healthy spinal cord. Journal of neuroimmunology 227:144-152. 20. Felts PA, Woolston AM, Fernando HB, Asquith S, Gregson NA, Mizzi OJ, Smith KJ (2005) Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 128:1649-1666. 21. Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. Journal of neuroimmunology 221:7-14. 22. Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221:7-14. 23. Gerhauser I, Alldinger S, Baumgärtner W (2007) Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis. Journal of neuroimmunology 188:86-94. 24. Gerhauser I, Hansmann F, Puff C, Kumnok J, Schaudien D, Wewetzer K, Baumgärtner W (2012) Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro. Journal of neuroimmunology 252:49-55. 25. Gudi V, Skuljec J, Yildiz O, Frichert K, Skripuletz T, Moharregh-Khiabani D, Voss E, Wissel K, Wolter S, Stangel M (2011) Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PloS one 6:e22623. 26. Haist V, Ulrich R, Kalkuhl A, Deschl U, Baumgärtner W (2012) Distinct SpatioTemporal Extracellular Matrix Accumulation within Demyelinated Spinal Cord Lesions in Theiler's Murine Encephalomyelitis. Brain Pathology 22:188-204. 27. Hamby ME, Coppola G, Ao Y, Geschwind DH, Khakh BS, Sofroniew MV (2012) Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors. J Neurosci 32:1448914510. 28. Herder V, Gerhauser I, Klein SK, Almeida P, Kummerfeld M, Ulrich R, Seehusen F, Rohn K, Schaudien D, Baumgärtner W, Huehn J, Beineke A (2012) Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis. J Neuroimmunol 249:27-39. 29. Hou W, Kang HS, Kim BS (2009) Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. The Journal of experimental medicine 206:313-328. 30. Jelachich ML, Bramlage C, Lipton HL (1999) Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis. Journal of virology 73:3227-3235.
Accepted Article
657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703
30 This article is protected by copyright. All rights reserved.
31. Jelachich ML, Lipton HL (1999) Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis. The Journal of general virology 80 ( Pt 7):1701-1705. 32. Jin YH, Hou W, Kang HS, Koh CS, Kim BS (2013) The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus. Journal of virology 87:11538-11551. 33. Kakalacheva K, Munz C, Lunemann JD (2011) Viral triggers of multiple sclerosis. Biochimica et biophysica acta 1812:132-140. 34. Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD (2000) Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. Journal of immunology 165:5304-5314. 35. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of neuroscience : the official journal of the Society for Neuroscience 29:13435-13444. 36. Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG (2007) Tolllike receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. Journal of Neurochemistry 102:37-50. 37. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, Sakamoto K, Hirakawa A, Takeuchi H, Suzumura A, Ishiguro N, Kadomatsu K (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell death & disease 4:e525. 38. Kreutzer M, Seehusen F, Kreutzer R, Pringproa K, Kummerfeld M, Claus P, Deschl U, Kalkul A, Beineke A, Baumgärtner W, Ulrich R (2012) Axonopathy is associated with complex axonal transport defects in a model of multiple sclerosis. Brain pathology 22:454-471. 39. Kummerfeld M, Meens J, Haas L, Baumgärtner W, Beineke A (2009) Generation and characterization of a polyclonal antibody for the detection of Theiler's murine encephalomyelitis virus by light and electron microscopy. Journal of virological methods 160:185-188. 40. Kummerfeld M, Seehusen F, Klein S, Ulrich R, Kreutzer R, Gerhauser I, Herder V, Baumgärtner W, Beineke A (2012) Periventricular demyelination and axonal pathology is associated with subependymal virus spread in a murine model for multiple sclerosis. Intervirology 55:401-416. 41. Kumnok J, Ulrich R, Wewetzer K, Rohn K, Hansmann F, Baumgärtner W, Alldinger S (2008) Differential transcription of matrix-metalloproteinase genes in primary mouse astrocytes and microglia infected with Theiler's murine encephalomyelitis virus. Journal of neurovirology 14:205-217. 42. Lalive PH, Paglinawan R, Biollaz G, Kappos EA, Leone DP, Malipiero U, Relvas JB, Moransard M, Suter T, Fontana A (2005) TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European journal of immunology 35:727-737. 43. Laskin DL (2009) Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chemical research in toxicology 22:1376-1385. 44. Lee MS, Kim B, Oh GT, Kim YJ (2013) OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7. Nature immunology 14:346-355.
Accepted Article
704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751
31 This article is protected by copyright. All rights reserved.
45. Lee MS, Park CH, Jeong YH, Kim YJ, Ha SJ (2013) Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8+ T-cell exhaustion. PLoS pathogens 9:e1003478. 46. Lipton HL (1975) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infection and immunity 11:1147-1155. 47. Liu C, Li Y, Yu J, Feng L, Hou S, Liu Y, Guo M, Xie Y, Meng J, Zhang H, Xiao B, Ma C (2013) Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. PloS one 8:e54841. 48. Liuzzi GM, Riccio P, Dal Canto MC (1995) Release of myelin basic proteindegrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice. Journal of Neuroimmunology 62:91-102. 49. Magnus T, Chan A, Grauer O, Toyka KV, Gold R (2001) Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. Journal of immunology 167:5004-5010. 50. Mahad DJ, Howell SJ, Woodroofe MN (2002) Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 73:320-323. 51. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-686. 52. Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130:28002815. 53. Markus S, Failing K, Baumgärtner W (2002) Increased expression of proinflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. Journal of neuroimmunology 125:30-41. 54. Martinez FO, Gordon S, Locati M, Mantovani A (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of immunology 177:7303-7311. 55. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nature medicine 11:335-339. 56. Mecha M, Carrillo-Salinas FJ, Mestre L, Feliu A, Guaza C (2013) Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus. Progress in neurobiology 101-102:46-64. 57. Mi W, Belyavskyi M, Johnson RR, Sieve AN, Storts R, Meagher MW, Welsh CJ (2004) Alterations in chemokine expression following Theiler's virus infection and restraint stress. J Neuroimmunol 151:103-115. 58. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G, Brochet B, Canron MH, Franconi JM, Boiziau C, Petry KG (2011) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Multiple sclerosis 17:2-15. 59. Miller SD, Olson JK, Croxford JL (2001) Multiple Pathways to Induction of Virus-Induced Autoimmune Demyelination: Lessons from Theiler's Virus Infection. Journal of Autoimmunity 16:219-227.
Accepted Article
752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798
32 This article is protected by copyright. All rights reserved.
60. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, KatzLevy Y, Carrizosa A, Kim BS (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nature medicine 3:1133-1136. 61. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJ, ffrench-Constant C (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211-1218. 62. Monteyne P (1999) Infection virale du système nerveux central: du modèle expérimental à l'application humaine. Annales Françaises d'Anesthésie et de Réanimation 18:550-553. 63. Munz C, Lunemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nature reviews Immunology 9:246-258. 64. Murray PD, McGavern DB, Pease LR, Rodriguez M (2002) Cellular sources and targets of IFN-gamma-mediated protection against viral demyelination and neurological deficits. Eur J Immunol 32:606-615. 65. Navarrete-Talloni MJ, Kalkuhl A, Deschl U, Ulrich R, Kummerfeld M, Rohn K, Baumgärtner W, Beineke A (2010) Transient Peripheral Immune Response and Central Nervous System Leaky Compartmentalization in a Viral Model for Multiple Sclerosis. Brain pathology 20:890-901. 66. Navarrete-Talloni MJ, Kalkuhl A, Deschl U, Ulrich R, Kummerfeld M, Rohn K, Baumgärtner W, Beineke A (2010) Transient peripheral immune response and central nervous system leaky compartmentalization in a viral model for multiple sclerosis. Brain pathology 20:890-901. 67. Olson JK, Girvin AM, Miller SD (2001) Direct activation of innate and antigenpresenting functions of microglia following infection with Theiler's virus. Journal of virology 75:9780-9789. 68. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990) T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187. 69. Pinteaux-Jones F, Sevastou IG, Fry VAH, Heales S, Baker D, Pocock JM (2008) Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. Journal of Neurochemistry 106:442-454. 70. Pope JG, Vanderlugt CL, Rahbe SM, Lipton HL, Miller SD (1998) Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus. Journal of virology 72:7762-7771. 71. Prajeeth CK, Löhr K, Floess S, Zimmermann J, Ulrich R, Gudi V, Beineke A, Baumgärtner W, Müller M, Huehn J, Stangel M (2014) Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia. Brain Behav Immun 37:248-259. 72. Qeska V, Barthel Y, Iseringhausen M, Tipold A, Stein VM, Khan MA, Baumgärtner W, Beineke A (2013) Dynamic changes of Foxp3(+) regulatory T cells in spleen and brain of canine distemper virus-infected dogs. Veterinary immunology and immunopathology 156:215-222. 73. Qin H, Yeh WI, De Sarno P, Holdbrooks AT, Liu Y, Muldowney MT, Reynolds SL, Yanagisawa LL, Fox TH, 3rd, Park K, Harrington LE, Raman C, Benveniste EN (2012) Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation.
Accepted Article
799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847
33 This article is protected by copyright. All rights reserved.
Proceedings of the National Academy of Sciences of the United States of America 109:5004-5009. 74. Raddatz BB, Hansmann F, Spitzbarth I, Kalkuhl A, Deschl U, Baumgärtner W, Ulrich R (2014) Transcriptomic meta-analysis of multiple sclerosis and its experimental models. PloS one 9:e86643. 75. Ransohoff RM, Wei T, Pavelko KD, Lee JC, Murray PD, Rodriguez M (2002) Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence. J Virol 76:2217-2224. 76. Rossi CP, Delcroix M, Huitinga I, McAllister A, van Rooijen N, Claassen E, Brahic M (1997) Role of macrophages during Theiler's virus infection. Journal of virology 71:3336-3340. 77. Rubio N, Arevalo MA, Cerciat M, Sanz-Rodriguez F, Unkila M, Garcia-Segura LM (2014) Theiler's virus infection provokes the overexpression of genes coding for the chemokine Ip10 (CXCL10) in SJL/J murine astrocytes, which can be inhibited by modulators of estrogen receptors. J Neurovirol 20:485-495. 78. Sakaki H, Tsukimoto M, Harada H, Moriyama Y, Kojima S (2013) Autocrine regulation of macrophage activation via exocytosis of ATP and activation of P2Y11 receptor. PLoS One 8:e59778. 79. Selenica ML, Alvarez JA, Nash KR, Lee DC, Cao C, Lin X, Reid P, Mouton PR, Morgan D, Gordon MN (2013) Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain. J Neuroinflammation 10:86. 80. Skripuletz T, Miller E, Moharregh-Khiabani D, Blank A, Pul R, Gudi V, Trebst C, Stangel M (2010) Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochemical research 35:1422-1433. 81. Sorensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103:807-815. 82. Spitzbarth I, Bock P, Haist V, Stein VM, Tipold A, Wewetzer K, Baumgärtner W, Beineke A (2011) Prominent microglial activation in the early proinflammatory immune response in naturally occurring canine spinal cord injury. Journal of neuropathology and experimental neurology 70:703-714. 83. Stein VM, Schreiner NMS, Moore PF, Vandevelde M, Zurbriggen A, Tipold A (2008) Immunophenotypical characterization of monocytes in canine distemper virus infection. Veterinary Microbiology 131:237-246. 84. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100:9440-9445. 85. Strack A, Asensio VC, Campbell IL, Schluter D, Deckert M (2002) Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma. Acta Neuropathol 103:458-468. 86. Tsunoda I (2008) Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future virology 3:579-593. 87. Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. Journal of neuropathology and experimental neurology 55:673-686.
Accepted Article
848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895
34 This article is protected by copyright. All rights reserved.
88. Tsunoda I, Fujinami RS (2002) Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination. Springer seminars in immunopathology 24:105-125. 89. Ulrich R, Baumgärtner W, Gerhauser I, Seeliger F, Haist V, Deschl U, Alldinger S (2006) MMP-12, MMP-3, and TIMP-1 are markedly upregulated in chronic demyelinating theiler murine encephalomyelitis. Journal of neuropathology and experimental neurology 65:783-793. 90. Ulrich R, Kalkuhl A, Deschl U, Baumgärtner W (2010) Machine learning approach identifies new pathways associated with demyelination in a viral model of multiple sclerosis. Journal of cellular and molecular medicine 14:434-448. 91. Ulrich R, Seeliger F, Kreutzer M, Germann PG, Baumgärtner W (2008) Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells. Neuropathol Appl Neurobiol 34:603-620. 92. Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD (2013) Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation 10:35. 93. Voss EV, Skuljec J, Gudi V, Skripuletz T, Pul R, Trebst C, Stangel M (2012) Characterisation of microglia during de- and remyelination: can they create a repair promoting environment? Neurobiology of disease 45:519-528. 94. Welch JS, Escoubet-Lozach L, Sykes DB, Liddiard K, Greaves DR, Glass CK (2002) TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J Biol Chem 277:42821-42829. 95. Yang LJS, Schnaar RL (2008) Axon regeneration inhibitors. Neurological research 30:1047-1052. 96. Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, Rowitch DH, Kessaris N, Suter U, Richardson WD, Franklin RJ (2010) CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 6:578-590. 97. Zoecklein LJ, Pavelko KD, Gamez J, Papke L, McGavern DB, Ure DR, Njenga MK, Johnson AJ, Nakane S, Rodriguez M (2003) Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus. Brain Pathol 13:291-308.
Accepted Article
896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931
35 This article is protected by copyright. All rights reserved.
Table 1: correlation between data obtained by gene expression analyses and immunofluorescence
Accepted Article
932 933
Gene expression
934 935 936 937 938
Immunofluorescence CD107b
CD68
CD16/32
Arginase-1
Ym1
Arginase-1
0.756*
0.686*
0.650*
0.630*
0.662*
Cd68
0.735*
0.751*
0.757*
0.708*
0.717*
Cd32b
0.722*
0.854*
0.760*
0.624*
0.720*
Cd16
0.723*
0.852*
0.804*
0.589*
0.691*
Cd107b
0.629*
0.629*
0.636*
0.476*
0.595*
Ym1
0.320
0.348
0.321
0.449*
0.563*
Spearman’s rank correlation coefficient was used to correlate absolute numbers (positive cells/spinal cord) of CD107b+, CD68+, CD16/32+, aginase-1+ and Ym1+ cells with the respective mRNA level measured by microarray analysis in the spinal cord of Theiler´s murine encephalomyelitis virus-infected mice. Significant differences of the correlation coefficient from zero are marked as follows: * = p≤0.01.
939
940 941
36 This article is protected by copyright. All rights reserved.
Accepted Article BPA_12238_F1
Accepted Article BPA_12238_F2
Accepted Article BPA_12238_F3
Accepted Article BPA_12238_F4
Accepted Article BPA_12238_F5
Accepted Article BPA_12238_F6